nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.513	0.691	CbGbCtD
Clonidine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.229	0.309	CbGbCtD
Clonidine—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00926	0.0514	CcSEcCtD
Clonidine—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00926	0.0514	CcSEcCtD
Clonidine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00543	0.0301	CcSEcCtD
Clonidine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00487	0.0271	CcSEcCtD
Clonidine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00443	0.0246	CcSEcCtD
Clonidine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0231	CcSEcCtD
Clonidine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0223	CcSEcCtD
Clonidine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0206	CcSEcCtD
Clonidine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00351	0.0195	CcSEcCtD
Clonidine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0189	CcSEcCtD
Clonidine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0189	CcSEcCtD
Clonidine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0176	CcSEcCtD
Clonidine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0163	CcSEcCtD
Clonidine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0153	CcSEcCtD
Clonidine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0027	0.015	CcSEcCtD
Clonidine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0146	CcSEcCtD
Clonidine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0138	CcSEcCtD
Clonidine—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00239	0.0616	CbGeAlD
Clonidine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0132	CcSEcCtD
Clonidine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0128	CcSEcCtD
Clonidine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0127	CcSEcCtD
Clonidine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0126	CcSEcCtD
Clonidine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00216	0.012	CcSEcCtD
Clonidine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.0021	0.054	CbGeAlD
Clonidine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0112	CcSEcCtD
Clonidine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.002	0.0111	CcSEcCtD
Clonidine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0111	CcSEcCtD
Clonidine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0109	CcSEcCtD
Clonidine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0107	CcSEcCtD
Clonidine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0019	0.049	CbGeAlD
Clonidine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0104	CcSEcCtD
Clonidine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0103	CcSEcCtD
Clonidine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0101	CcSEcCtD
Clonidine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00979	CcSEcCtD
Clonidine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00964	CcSEcCtD
Clonidine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00962	CcSEcCtD
Clonidine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00957	CcSEcCtD
Clonidine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00957	CcSEcCtD
Clonidine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00899	CcSEcCtD
Clonidine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00892	CcSEcCtD
Clonidine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00872	CcSEcCtD
Clonidine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00867	CcSEcCtD
Clonidine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00859	CcSEcCtD
Clonidine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0085	CcSEcCtD
Clonidine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00842	CcSEcCtD
Clonidine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00821	CcSEcCtD
Clonidine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00813	CcSEcCtD
Clonidine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00146	0.0376	CbGeAlD
Clonidine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00805	CcSEcCtD
Clonidine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00784	CcSEcCtD
Clonidine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00777	CcSEcCtD
Clonidine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00769	CcSEcCtD
Clonidine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00765	CcSEcCtD
Clonidine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00755	CcSEcCtD
Clonidine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00751	CcSEcCtD
Clonidine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0074	CcSEcCtD
Clonidine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00736	CcSEcCtD
Clonidine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0073	CcSEcCtD
Clonidine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00713	CcSEcCtD
Clonidine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00713	CcSEcCtD
Clonidine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0071	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00708	CcSEcCtD
Clonidine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00704	CcSEcCtD
Clonidine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00697	CcSEcCtD
Clonidine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00689	CcSEcCtD
Clonidine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00683	CcSEcCtD
Clonidine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00679	CcSEcCtD
Clonidine—NISCH—medulla oblongata—amyotrophic lateral sclerosis	0.00122	0.0314	CbGeAlD
Clonidine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00672	CcSEcCtD
Clonidine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0067	CcSEcCtD
Clonidine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00669	CcSEcCtD
Clonidine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00667	CcSEcCtD
Clonidine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00664	CcSEcCtD
Clonidine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0066	CcSEcCtD
Clonidine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00651	CcSEcCtD
Clonidine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00638	CcSEcCtD
Clonidine—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00115	0.0295	CbGeAlD
Clonidine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00622	CcSEcCtD
Clonidine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00618	CcSEcCtD
Clonidine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00613	CcSEcCtD
Clonidine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00609	CcSEcCtD
Clonidine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00607	CcSEcCtD
Clonidine—NISCH—spinal cord—amyotrophic lateral sclerosis	0.00108	0.028	CbGeAlD
Clonidine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00594	CcSEcCtD
Clonidine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0059	CcSEcCtD
Clonidine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00589	CcSEcCtD
Clonidine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00584	CcSEcCtD
Clonidine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00584	CcSEcCtD
Clonidine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00563	CcSEcCtD
Clonidine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00559	CcSEcCtD
Clonidine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000978	0.00543	CcSEcCtD
Clonidine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000973	0.0054	CcSEcCtD
Clonidine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000973	0.0054	CcSEcCtD
Clonidine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000907	0.00503	CcSEcCtD
Clonidine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.0009	0.0232	CbGeAlD
Clonidine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000883	0.0049	CcSEcCtD
Clonidine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000871	0.00483	CcSEcCtD
Clonidine—NISCH—cerebellum—amyotrophic lateral sclerosis	0.00086	0.0222	CbGeAlD
Clonidine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000859	0.0222	CbGeAlD
Clonidine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000842	0.00467	CcSEcCtD
Clonidine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.000836	0.0216	CbGeAlD
Clonidine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000814	0.00452	CcSEcCtD
Clonidine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00434	CcSEcCtD
Clonidine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00078	0.0201	CbGeAlD
Clonidine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000776	0.00431	CcSEcCtD
Clonidine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000775	0.0043	CcSEcCtD
Clonidine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000771	0.00428	CcSEcCtD
Clonidine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.000763	0.0197	CbGeAlD
Clonidine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.000751	0.0194	CbGeAlD
Clonidine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.000735	0.0189	CbGeAlD
Clonidine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000731	0.00406	CcSEcCtD
Clonidine—SLC22A4—spinal cord—amyotrophic lateral sclerosis	0.000717	0.0185	CbGeAlD
Clonidine—NISCH—brain—amyotrophic lateral sclerosis	0.000699	0.018	CbGeAlD
Clonidine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000627	0.0162	CbGeAlD
Clonidine—ADRA1B—brain—amyotrophic lateral sclerosis	0.000596	0.0154	CbGeAlD
Clonidine—ADRA1D—brain—amyotrophic lateral sclerosis	0.000583	0.015	CbGeAlD
Clonidine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.000575	0.0148	CbGeAlD
Clonidine—SLC22A4—cerebellum—amyotrophic lateral sclerosis	0.000569	0.0147	CbGeAlD
Clonidine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.000556	0.0143	CbGeAlD
Clonidine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000554	0.0143	CbGeAlD
Clonidine—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.00055	0.0142	CbGeAlD
Clonidine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.000532	0.0137	CbGeAlD
Clonidine—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.00053	0.0137	CbGeAlD
Clonidine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.000496	0.0128	CbGeAlD
Clonidine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000493	0.0127	CbGeAlD
Clonidine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.000475	0.0122	CbGeAlD
Clonidine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000471	0.0122	CbGeAlD
Clonidine—SLC22A4—brain—amyotrophic lateral sclerosis	0.000462	0.0119	CbGeAlD
Clonidine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000454	0.0117	CbGeAlD
Clonidine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000443	0.0114	CbGeAlD
Clonidine—SLC22A1—brain—amyotrophic lateral sclerosis	0.00044	0.0113	CbGeAlD
Clonidine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000438	0.0113	CbGeAlD
Clonidine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000422	0.0109	CbGeAlD
Clonidine—SLC22A3—brain—amyotrophic lateral sclerosis	0.00042	0.0108	CbGeAlD
Clonidine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000418	0.0108	CbGeAlD
Clonidine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000412	0.0106	CbGeAlD
Clonidine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000402	0.0104	CbGeAlD
Clonidine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000395	0.0102	CbGeAlD
Clonidine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000393	0.0101	CbGeAlD
Clonidine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000387	0.00997	CbGeAlD
Clonidine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.000376	0.0097	CbGeAlD
Clonidine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00036	0.00929	CbGeAlD
Clonidine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000357	0.00922	CbGeAlD
Clonidine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000344	0.00887	CbGeAlD
Clonidine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000335	0.00864	CbGeAlD
Clonidine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000333	0.00859	CbGeAlD
Clonidine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000321	0.00827	CbGeAlD
Clonidine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000319	0.00823	CbGeAlD
Clonidine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000314	0.00808	CbGeAlD
Clonidine—SLC22A5—brain—amyotrophic lateral sclerosis	0.000306	0.00788	CbGeAlD
Clonidine—CYP1A1—brain—amyotrophic lateral sclerosis	0.000273	0.00704	CbGeAlD
Clonidine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000262	0.00676	CbGeAlD
Clonidine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000258	0.00665	CbGeAlD
Clonidine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000255	0.00657	CbGeAlD
Clonidine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000252	0.00651	CbGeAlD
Clonidine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000248	0.00641	CbGeAlD
Clonidine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000247	0.00637	CbGeAlD
Clonidine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000243	0.00626	CbGeAlD
Clonidine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00022	0.00568	CbGeAlD
Clonidine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000197	0.00509	CbGeAlD
Clonidine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000186	0.00479	CbGeAlD
Clonidine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000179	0.00461	CbGeAlD
Clonidine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000175	0.0045	CbGeAlD
Clonidine—ABCB1—brain—amyotrophic lateral sclerosis	0.000142	0.00366	CbGeAlD
Clonidine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.15e-05	0.000796	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.08e-05	0.000779	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.08e-05	0.000779	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.06e-05	0.000774	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.05e-05	0.000771	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.03e-05	0.000767	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—GSR—amyotrophic lateral sclerosis	3.03e-05	0.000767	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3e-05	0.000758	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.98e-05	0.000755	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.98e-05	0.000755	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.95e-05	0.000746	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.94e-05	0.000744	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.9e-05	0.000735	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.9e-05	0.000734	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.9e-05	0.000734	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.86e-05	0.000724	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.86e-05	0.000724	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.81e-05	0.000711	CbGpPWpGaD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.8e-05	0.000707	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.76e-05	0.000699	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.75e-05	0.000695	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	2.74e-05	0.000694	CbGpPWpGaD
Clonidine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.71e-05	0.000685	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.7e-05	0.000684	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.7e-05	0.000682	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.69e-05	0.000681	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.69e-05	0.00068	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.69e-05	0.00068	CbGpPWpGaD
Clonidine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.67e-05	0.000675	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	2.67e-05	0.000675	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.66e-05	0.000673	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.62e-05	0.000663	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.62e-05	0.000663	CbGpPWpGaD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.61e-05	0.000661	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.58e-05	0.000653	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.54e-05	0.000643	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.54e-05	0.000642	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.54e-05	0.000642	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.52e-05	0.000638	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.51e-05	0.000634	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.5e-05	0.000631	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CHAT—amyotrophic lateral sclerosis	2.49e-05	0.00063	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.47e-05	0.000624	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000623	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	2.46e-05	0.000623	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.46e-05	0.000622	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.45e-05	0.000619	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	2.44e-05	0.000618	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.43e-05	0.000616	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.43e-05	0.000616	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.41e-05	0.000609	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.4e-05	0.000607	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.38e-05	0.000603	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.37e-05	0.0006	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.33e-05	0.00059	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.31e-05	0.000584	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.29e-05	0.00058	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.28e-05	0.000578	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.26e-05	0.000571	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	2.26e-05	0.000571	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.25e-05	0.00057	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.23e-05	0.000564	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.23e-05	0.000564	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.21e-05	0.000558	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.19e-05	0.000555	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.15e-05	0.000543	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.14e-05	0.000541	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.13e-05	0.000539	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.12e-05	0.000537	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.1e-05	0.000532	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.1e-05	0.00053	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.09e-05	0.000529	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.08e-05	0.000526	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.07e-05	0.000525	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.07e-05	0.000525	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.07e-05	0.000524	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.07e-05	0.000524	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	0.000522	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.06e-05	0.000521	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.05e-05	0.000518	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	2.02e-05	0.000511	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	0.00051	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.01e-05	0.000508	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.99e-05	0.000503	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.94e-05	0.000491	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.94e-05	0.000491	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.000491	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.92e-05	0.000487	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.9e-05	0.00048	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000471	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.85e-05	0.000469	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.84e-05	0.000467	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.84e-05	0.000465	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.82e-05	0.000461	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.82e-05	0.00046	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.81e-05	0.000459	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.76e-05	0.000446	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.75e-05	0.000443	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.74e-05	0.00044	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.74e-05	0.00044	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.71e-05	0.000433	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.71e-05	0.000432	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.7e-05	0.000431	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.7e-05	0.000429	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.69e-05	0.000428	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.69e-05	0.000428	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.67e-05	0.000423	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.67e-05	0.000422	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.66e-05	0.000419	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	1.66e-05	0.000419	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.65e-05	0.000417	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.65e-05	0.000416	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.6e-05	0.000406	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.6e-05	0.000404	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.59e-05	0.000402	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.54e-05	0.000389	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.53e-05	0.000387	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.52e-05	0.000385	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.51e-05	0.000383	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.51e-05	0.000383	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.5e-05	0.000379	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.48e-05	0.000374	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.47e-05	0.000372	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.44e-05	0.000365	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.44e-05	0.000363	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.43e-05	0.000362	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.41e-05	0.000357	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.41e-05	0.000356	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	0.000354	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.38e-05	0.000348	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.37e-05	0.000346	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.36e-05	0.000344	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.35e-05	0.000341	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.34e-05	0.00034	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.34e-05	0.000339	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.34e-05	0.000338	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.32e-05	0.000334	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.32e-05	0.000333	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.3e-05	0.000328	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.28e-05	0.000324	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.28e-05	0.000323	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.26e-05	0.000318	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.25e-05	0.000316	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.25e-05	0.000316	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.25e-05	0.000315	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000313	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000311	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.22e-05	0.000308	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.18e-05	0.000298	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.17e-05	0.000297	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.17e-05	0.000296	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.16e-05	0.000294	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.14e-05	0.000287	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.14e-05	0.000287	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.12e-05	0.000282	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.12e-05	0.000282	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.000278	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.000277	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.09e-05	0.000277	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.09e-05	0.000277	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.09e-05	0.000276	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.09e-05	0.000275	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.09e-05	0.000275	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.08e-05	0.000272	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.08e-05	0.000272	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.05e-05	0.000265	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.04e-05	0.000262	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.00026	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000258	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.02e-05	0.000257	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000256	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000256	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1e-05	0.000254	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.98e-06	0.000253	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.95e-06	0.000252	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.72e-06	0.000246	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	9.69e-06	0.000245	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.55e-06	0.000242	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.4e-06	0.000238	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.15e-06	0.000231	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.08e-06	0.00023	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.05e-06	0.000229	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.98e-06	0.000227	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.94e-06	0.000226	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.88e-06	0.000225	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.64e-06	0.000219	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.61e-06	0.000218	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.46e-06	0.000214	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.35e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.32e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.28e-06	0.00021	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	8.26e-06	0.000209	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	8.21e-06	0.000208	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.94e-06	0.000201	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	7.53e-06	0.00019	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.51e-06	0.00019	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.48e-06	0.000189	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.39e-06	0.000187	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.38e-06	0.000187	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.11e-06	0.00018	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.08e-06	0.000179	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.99e-06	0.000177	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.98e-06	0.000176	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.93e-06	0.000175	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.9e-06	0.000175	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.88e-06	0.000174	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.87e-06	0.000174	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.64e-06	0.000168	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.5e-06	0.000165	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.38e-06	0.000161	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.11e-06	0.000155	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.03e-06	0.000152	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6e-06	0.000152	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.76e-06	0.000146	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.68e-06	0.000144	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.67e-06	0.000144	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.63e-06	0.000142	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.51e-06	0.000139	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.44e-06	0.000138	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.41e-06	0.000137	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.38e-06	0.000136	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.35e-06	0.000135	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.29e-06	0.000134	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.16e-06	0.00013	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.08e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5e-06	0.000127	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.89e-06	0.000124	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.87e-06	0.000123	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.7e-06	0.000119	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.63e-06	0.000117	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.56e-06	0.000115	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.53e-06	0.000115	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.49e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.44e-06	0.000112	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.37e-06	0.000111	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.25e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.13e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.09e-06	0.000103	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.99e-06	0.000101	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.89e-06	9.85e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.71e-06	9.38e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.69e-06	9.34e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.67e-06	9.28e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.5e-06	8.85e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.45e-06	8.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.39e-06	8.59e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.11e-06	7.86e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.01e-06	7.63e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.8e-06	7.09e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.4e-06	6.07e-05	CbGpPWpGaD
